NEW YORK, July 19 - With $15 million in venture financing, Gene Logic said Thursday it has spun off a new company, Metrigenix, that will develop and commercialize its Flow-thru Chip microarray. 

Metrigenix.will market the Flow-thru Chip as a custom and pre-fabricated gene-based screening array to  pharmaceutical, biotechnology, and other life sciences companies. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.